Monthly Archives: July 2020

Patented Medicines Regulations: UPDATE July 13, 2020

financial charts

As reported by Kelsey Rolfe of Benefits Canada, reforms to the Patented Medicines Pricing Review Board (PMPRB) have been upheld by the Federal Court. This decision followed an application for judicial review by Innovative Medicines Canada and 16 pharmaceutical companies who opposed the amendments which included: In setting drug prices, a “basket” of 11 other […]